M. Alexander Shaw
Chief Executive Officer at Prolifagen LLC
Profile
M.
Alexander Shaw is currently the Chief Executive Officer at Prolifagen LLC since 2022.
Prior to this, he was the Chief Operating Officer at Nuventra, Inc. from 2009 to 2021.
He received his undergraduate degree from Duke University and his doctorate degree from Washington State University.
M. Alexander Shaw active positions
| Companies | Position | Start |
|---|---|---|
| Prolifagen LLC | Chief Executive Officer | 12/09/2022 |
Former positions of M. Alexander Shaw
| Companies | Position | End |
|---|---|---|
Nuventra, Inc.
 Nuventra, Inc. Miscellaneous Commercial ServicesCommercial Services Nuventra, Inc. provides clinical pharmacology consulting services. Its services include pharmacokinetics and PK and PD analysis, clinpharm, toxicokinetics, clinical pharmacology trials, strategic plannign, regulatory, scientific and medical writing, due diligence, comparator PK/PD analysis, and PK/PD data management. The company was founded by Geoffrey Banks in 2008 and is headquartered in Durham, NC. | Chief Operating Officer | 30/09/2021 |
Training of M. Alexander Shaw
| Duke University | Undergraduate Degree |
| Washington State University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Nuventra, Inc.
Nuventra, Inc. Miscellaneous Commercial ServicesCommercial Services Nuventra, Inc. provides clinical pharmacology consulting services. Its services include pharmacokinetics and PK and PD analysis, clinpharm, toxicokinetics, clinical pharmacology trials, strategic plannign, regulatory, scientific and medical writing, due diligence, comparator PK/PD analysis, and PK/PD data management. The company was founded by Geoffrey Banks in 2008 and is headquartered in Durham, NC. | Commercial Services |
| Prolifagen LLC |
- Stock Market
- Insiders
- M. Alexander Shaw
